GleamWall
中文EN

NAII NATURAL ALTERNATIVES INTERNATIONAL INC

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 787253 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY-1.1%
TTM net income YoY-92.6%
TTM EPS YoY-89.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin4.4%
Operating margin-16.3%
Net margin-17.2%
FCF margin-5.0%
EBITDA margin-12.8%

Returns

ROE-39.4%
ROA-16.9%
ROIC (approx.)-30.3%
Asset turnover0.98x

Leverage & solvency

Liabilities / assets58.8%
Debt / equity0.23x
Current ratio1.37x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.16x
Accruals ratio-14.1%
Payout ratio—
Capex / revenue2.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-09-302026Q4*2026-06-302026Q32026-03-312026Q22025-12-312026Q12025-09-302025Q4*2025-06-302025Q32025-03-312025Q22024-12-31
Income statement
Revenue$28.12M$34.51M$35.48M$34.80M$37.73M$33.87M$28.77M$34.08M
Cost of revenue$26.86M$32.78M$35.10M$32.30M$33.33M$30.33M$26.94M$32.41M
Gross profit$1.27M$1.73M$383,000$2.49M$4.40M$3.54M$1.83M$1.67M
SG&A expense$3.85M—$4.40M$4.34M$4.11M—$3.93M$4.45M
Operating income-$2.58M-$13.18M-$4.01M-$1.85M$284,000-$1.94M-$2.10M-$2.78M
Pretax income-$2.74M-$13.49M-$4.24M-$2.33M-$199,000-$2.82M-$2.64M-$2.87M
Income tax-$265,000$46,000$68,000$224,000$92,000$4.40M-$456,000-$675,000
Net income-$2.48M-$13.54M-$4.31M-$2.55M-$291,000-$7.22M-$2.19M-$2.19M
EBITDA-$1.54M-$11.99M-$2.82M-$681,000$1.45M-$784,000-$961,000-$1.65M
EPS (basic)-0.41—-0.72-0.42-0.05—-0.37-0.37
EPS (diluted)-0.41—-0.72-0.42-0.05—-0.37-0.37
Weighted avg. shares (diluted)6.07M—6.03M6.01M6.01M—5.94M5.92M
Banking
Net interest income-$560,000-$466,000-$270,000-$224,000-$226,000-$212,000-$246,000-$278,000
Balance sheet
Cash & equivalents$6.49M$7.39M$9.20M$7.39M$7.74M$12.32M$10.61M$8.66M
Receivables$12.43M$20.65M$20.59M$20.65M$18.91M$14.64M$11.65M$16.90M
Inventory$28.16M$30.75M$29.93M$30.75M$30.65M$24.87M$26.99M$23.04M
Current assets$54.30M$65.43M$63.99M$65.43M$65.05M$59.28M$58.52M$58.55M
PP&E, net$35.33M$35.60M$50.81M$35.60M$50.79M$50.89M$50.56M$50.94M
Total assets$114.53M$126.45M$154.88M$126.45M$156.94M$151.94M$154.94M$156.13M
Current liabilities$39.58M$37.72M$39.12M$37.72M$33.90M$28.80M$23.31M$21.65M
Long-term debt$10.80M$10.90M——————
Total debt$10.80M$10.90M——————
Total liabilities$67.34M$76.49M$91.77M$76.49M$87.92M$83.51M$78.33M$76.99M
Shareholders' equity$47.19M$49.96M$63.11M$49.96M$69.02M$68.43M$76.62M$79.14M
Net debt$4.32M$3.51M——————
Shares outstanding6.26M6.27M6.28M6.27M6.18M6.18M6.18M6.20M
Cash flow statement
Operating cash flow$1.20M-$1.07M$2.50M-$6.33M-$4.02M$3.35M$5.99M$37,000
Capital expenditure$264,000$637,000$1.10M$934,000$1.03M$1.46M$802,000$1.06M
Free cash flow$932,000-$1.70M$1.40M-$7.26M-$5.05M$1.89M$5.19M-$1.02M
Investing cash flow-$264,000-$637,000-$1.10M-$934,000-$1.03M-$1.46M-$802,000-$1.06M
Financing cash flow-$1.66M-$19,000$4.04M$3.27M$472,000-$176,000-$3.24M-$474,000
Depreciation & amortization$1.04M$1.18M$1.19M$1.17M$1.17M$1.16M$1.14M$1.13M
Stock-based compensation$91,000$108,000$140,000$178,000$177,000$179,000$245,000$277,000
Share buybacks$3,000$2,000$82,000$0$5,000$2,000$168,000$0

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.